The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Allergic reactions to COVID-19 vaccine ranging from mild to severe have been reported in patients with a history of anaphylaxis. Currently, no guidelines are available regarding prevention of allergic reactions in patients with high-risk of anaphylaxis who plan on receiving the SARS-CoV-2 vaccine. In this case-series study, two patients with a history of anaphylaxis had taken antihistaminic drugs...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.